# CG Oncology (CGON) — News

CGON · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cgon/news

## Recent headlines

- [CG Oncology appoints proven biopharmaceutical commercial leader Isabel Kalofonos as chief commercial officer](https://www.ainvest.com/news/cg-oncology-appoints-proven-biopharmaceutical-commercial-leader-isabel-kalofonos-chief-commercial-officer-2610) — AInvest Wire, Oct 13, 2026
- [CG Oncology Q2 revenue USD 1.157 million](https://www.ainvest.com/news/cg-oncology-q2-revenue-usd-1-157-million-2608) — AInvest Wire, Aug 6, 2026
  CG Oncology, Inc. (NASDAQ: CGON) reported second-quarter 2025 revenue of $1.157 million , according to its financial results for the period ended June 30, 2025. This represents a significant decline from $640,000 in revenue recorded during the same period in 2024. The company’s revenue primarily…
- [CG Oncology Q2 EPS USD -0.9](https://www.ainvest.com/news/cg-oncology-q2-eps-usd-0-9-2608) — AInvest Wire, Aug 6, 2026
- [CG Oncology Inc - files for offering of up to $500 mln common stock - SEC filing](https://www.ainvest.com/news/cg-oncology-files-offering-500-mln-common-stock-sec-filing-2608) — AInvest Wire, Aug 6, 2026
- [ANI Pharmaceuticals Inc: Continue to seek to recover value of assets it sold to CG Oncology in 2010](https://www.ainvest.com/news/ani-pharmaceuticals-continue-seek-recover-assets-sold-cg-oncology-2010-2607) — AInvest Wire, Jul 16, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).